Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Pertussis cost-effectiveness of therapy
Introduction
Cost Effectiveness of Therapy
Cost Effectiveness of Therapy
- Given the morbidity of of Pertussis, the cost-effectiveness of treatment is substantial.
- A retrospective assessment of medical costs of confirmed pertussis in 936 adults in Massachusetts during 1998 to 2000, and a prospective assessment of nonmedical costs in 203 adults during 2001 to 2003 indicated that the mean medical and nonmedical cost per case was $326 and $447, respectively, for a societal cost of $773._Prevention_of_pertussis,_tetanus,_and_diphtheria_among_pregnant_and_postpartum_women_and_their_infants._Recommendations_of_the_Advisory_Committee_on_Immunization_Practices_(ACIP).-1|[1]
- If the cost of antimicrobials to treat contacts and the cost of personal time were included, the societal cost could be as high as $1,952 per adult case._Prevention_of_pertussis,_tetanus,_and_diphtheria_among_pregnant_and_postpartum_women_and_their_infants._Recommendations_of_the_Advisory_Committee_on_Immunization_Practices_(ACIP).-1|[1]
Cost Effectiveness of Vaccination
Cost Effectiveness of Vaccination
- Cost-benefit and cost-effectiveness analyses of adult Tdap vaccination have varied in their results. When discrepancies in the models were addressed, an adult Tdap vaccination program was cost-effective when incidence of pertussis exceeded 120 cases per 100,000 population, using a benchmark of $50,000 per quality-adjusted life year saved. [2]
References
References
- ↑ _Prevention_of_pertussis,_tetanus,_and_diphtheria_among_pregnant_and_postpartum_women_and_their_infants._Recommendations_of_the_Advisory_Committee_on_Immunization_Practices_(ACIP)._1-0|1.0 _Prevention_of_pertussis,_tetanus,_and_diphtheria_among_pregnant_and_postpartum_women_and_their_infants._Recommendations_of_the_Advisory_Committee_on_Immunization_Practices_(ACIP)._1-1|1.1 “National Guideline Clearinghouse | Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants. Recommendations of the Advisory Committee on Immunization Practices (ACIP)”.
- ↑ Lee GM, Murphy TV, Lett S, Cortese MM, Kretsinger K, Schauer S, Lieu TA (2007). “Cost effectiveness of pertussis vaccination in adults”. Am J Prev Med. 32 (3): 186–193. doi:10.1016/j.amepre.2006.10.016. PMID 17296470.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Â ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2] Luke Rusowicz-Orazem, B.S.